Advertisement
When should a housing society in Mumbai start considering re...
From GST on JDAs to SEBI’s REIT reclassification and the S...
Stay ahead in the world of real estate with our daily podcas...
Stay ahead in the world of real estate with our daily podcas...
Alexandria Real Estate Equities Inc has priced a public offering of USD 750 million in senior unsecured notes carrying a 5.25 percent interest rate, with maturity scheduled for 2036. The issuance adds long-term fixed-rate debt to the company's balance sheet and aligns with its established approach of matching funding tenures with long-duration life science assets. As a major US-listed REIT focused on laboratory and research properties, Alexandria has frequently tapped public debt markets to support development activity, refinance obligations, and maintain financial flexibility.
Alexandria Real Estate Equities Inc has priced a public offering of senior unsecured notes amounting to USD 750 million, according to a regulatory update released in the past week. The notes carry a fixed interest rate of 5.25 percent and will mature in 2036, adding a long-term debt instrument to the company's capital structure. Advertisement
The offering forms part of the life science focused real estate investment trust's broader funding strategy, which has traditionally relied on a mix of unsecured notes, term loans, and equity issuances to support development and balance sheet stability. Alexandria has regularly accessed the bond market over the past decade, using longer-dated maturities to align financing with the extended lease tenures typical of its laboratory and research campuses.
Senior notes rank ahead of subordinated obligations and are commonly used by large listed REITs to secure predictable funding at fixed costs. The newly priced issuance strengthens Alexandria's liquidity position while extending its weighted average debt maturity profile. The company has not indicated any change in its core investment strategy following the transaction.
Alexandria Real Estate Equities is listed on the New York Stock Exchange under the ticker ARE and is known for its concentration in urban life science clusters across major US markets. The proceeds from similar past offerings have typically been directed toward refinancing existing debt, funding ongoing development pipelines, and supporting general corporate purposes.
Source Reuters
5th Jun, 2025
25th May, 2023
11th May, 2023
27th Apr, 2023
Advertisement
Facebook
Whatsapp
